---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-021359"
form_type: "8-K"
ticker: "OCGN"
cik: "0001372299"
company_name: "Ocugen, Inc."
filed_at: "2025-05-01T23:59:59+00:00"
generated_at: "2026-05-23T00:01:25.415140+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Ocugen presents clinical trial data at Eyecelerator conference

## Summary
- Presentation furnished as Exhibit 99.1; used at May 2, 2025 Eyecelerator showcase.
- Data shows mean change in BCVA and visual field responder proportions.
- Specific numerical results not fully extractable due to formatting in filing text.
- No new financial results, guidance, or corporate updates provided.

## SEC filing metadata
- accession: 0001628280-25-021359
- form_type: 8-K
- ticker: OCGN
- cik: 0001372299
- company_name: Ocugen, Inc.
- filed_at: 2025-05-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372299/000162828025021359/0001628280-25-021359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372299/000162828025021359/ocgn-20250501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-021359
- JSON: https://secwatch.observer/filing/0001628280-25-021359.json
- Plain text: https://secwatch.observer/filing/0001628280-25-021359.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.